A detailed history of Zions Bancorporation, N.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 6 shares of UTHR stock, worth $2,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 8 25.0%
Holding current value
$2,185
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$311.04 - $363.55 $622 - $727
-2 Reduced 25.0%
6 $2,000
Q3 2023

Nov 07, 2023

BUY
$211.82 - $248.24 $1,694 - $1,985
8 New
8 $1,000
Q1 2023

May 10, 2023

BUY
$212.99 - $276.17 $638 - $828
3 New
3 $0
Q2 2022

Aug 05, 2022

SELL
$174.81 - $241.14 $6,467 - $8,922
-37 Reduced 10.05%
331 $78,000
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $61,146 - $78,737
368 New
368 $66,000
Q2 2019

Jul 09, 2019

SELL
$76.06 - $120.81 $456 - $724
-6 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$101.4 - $128.73 $608 - $772
6 New
6 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.